Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sydney Kuzoian
Institutions:
University of Connecticut,
Connecticut Children's Medical Center,
UConn Health
Observed institutions:
University of Connecticut,
Connecticut Children's Medical Center,
UConn Health
ORCID:
0009-0006-8271-2301
Observed ORCID:
0009-0006-8271-2301
OpenAlex ID:
A5096229551
Sleep tracking and sleep hygiene counseling improve fatigue in pediatric patients with inflammatory bowel disease
2025
·
Sydney Kuzoian
, Bradley Jerson
, et al.
·
Journal of Pediatric Gastroenterology and Nutrition
·
6
Change from originator infliximab to biosimilar does not affect 1‐year outcome in children with inflammatory bowel disease
2024
·
Viven Solomon
, Sydney Kuzoian
, et al.
·
JPGN Reports
·
2
PDF
Cyproheptadine: The secret sauce
2026
·
Corey Baker
, Sydney Kuzoian
, et al.
·
Journal of Pediatric Gastroenterology and Nutrition
·
1
Diarrhea
2025
·
Peter Townsend
, Sydney Kuzoian
·
Elsevier eBooks
Tu1817 CHANGE FROM REMICADE® TO INFLIXIMAB BIOSIMILAR DOES NOT AFFECT SHORT-TERM OUTCOME IN CHILDREN WITH INFLAMMATORY BOWEL DISEASE.
2024
·
Viven Solomon
, Sydney Kuzoian
, et al.
·
Gastroenterology
Show more works
View as search
Works count:
6
Citation count:
9
H-index:
2
I10-index:
Year
Topic
Type